|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
Sec Filings Insider Trading - MAP Pharmaceuticals Inc. (MAPP)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |
MAP Pharmaceuticals Inc: Insider Trading and Stock Options
Common stock purchase or sale:
| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2009-11-18 Sale |
2009-11-19 4:31 pm | MAP Pharmaceuticals, Inc. | MAPP | HENWOOD GERALDINE (Director) | 16,250 | $8.766 | $142,444 | 0 (Direct) | View |
| 2009-11-02 Sale | 2009-11-04 2:15 pm |
MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 4,500 | $8.06 | $36,268 | 729 (Direct) |
View |
| 2009-11-02 Sale | 2009-11-04 2:13 pm | MAP Pharmaceuticals, Inc. | MAPP | CHAI CHRISTOPHER Y (Chief Financial Officer) | 10,000 | $8.072 | $80,722 | 4,979 (Direct) | View |
| 2009-10-01 Sale |
2009-10-05 5:19 pm |
MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 4,500 | $10.2 | $45,880 | 729 (Direct) | View |
| 2009-10-01 Sale | 2009-10-05 5:15 pm |
MAP Pharmaceuticals, Inc. | MAPP | CHAI CHRISTOPHER Y (Chief Financial Officer) | 10,000 | $10.26 | $102,624 | 4,979 (Direct) |
View |
| 2009-09-08 Sale |
2009-09-10 12:02 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 4,500 | $10.03 | $45,127 | 729 (Direct) |
View |
| 2009-07-14- -2009-07-15 Sale |
2009-07-16 12:54 pm | MAP Pharmaceuticals, Inc. | MAPP | FirstMark Capital, L.L.C. (See footnote 1) | 9,700 | $10.56 | $102,393 | 2,024,422 (Indirect) | View |
| 2009-07-10 Sale | 2009-07-14 5:26 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 25,000 | $10.16 | $254,000 | 729 (Direct) |
View |
| 2009-07-02 Sale | 2009-07-06 3:09 pm | MAP Pharmaceuticals, Inc. | MAPP | FirstMark Capital, L.L.C. (See Footnote 1) | 2,400 | $12 | $28,807 | 2,034,122 (Indirect) |
View |
| 2009-07-01 Sale | 2009-07-02 4:45 pm | MAP Pharmaceuticals, Inc. | MAPP | FirstMark Capital, L.L.C. (See Footnote 1) | 45,000 | $12.09 | $544,059 | 2,036,522 (Indirect) | View |
| 2009-06-26 Sale | 2009-06-29 7:16 pm |
MAP Pharmaceuticals, Inc. | MAPP | FirstMark Capital, L.L.C. (See Footnote 1) | 43,577 | $11.36 | $495,120 | 2,081,522 (Indirect) |
View |
| 2009-06-26 Sale |
2009-06-29 5:44 pm |
MAP Pharmaceuticals, Inc. | MAPP | FirstMark Capital, L.L.C. (See Footnote 1) | 88,523 | $11.1 | $982,183 | 2,125,099 (Indirect) |
View |
| 2009-06-23- -2009-06-24 Sale | 2009-06-25 3:14 pm |
MAP Pharmaceuticals, Inc. | MAPP | FirstMark Capital, L.L.C. (See Footnote 1) | 5,508 | $11.17 | $61,534 | 2,213,622 (Indirect) | View |
| 2009-06-23 Sale |
2009-06-24 4:35 pm | MAP Pharmaceuticals, Inc. | MAPP | FirstMark Capital, L.L.C. (See Footnote 1) | 73,476 | $11.11 | $816,114 | 2,219,130 (Indirect) |
View |
| 2009-06-19 Sale |
2009-06-23 8:09 pm | MAP Pharmaceuticals, Inc. | MAPP | FirstMark Capital, L.L.C. (See Footnote 1) | 1,403 | $11.5 | $16,134 | 2,292,606 (Indirect) |
View |
| 2009-06-19 Sale(C) | 2009-06-23 7:28 pm | MAP Pharmaceuticals, Inc. | MAPP | FirstMark Capital, L.L.C. (See Footnote 1) | 37,513 | $11.11 | $416,611 | 2,294,009 (Indirect) | View |
| 2009-05-28 Sale | 2009-05-29 7:37 pm |
MAP Pharmaceuticals, Inc. | MAPP | FirstMark Capital, L.L.C. (See Footnote 1) | 11,450 | $13.51 | $154,667 | 2,331,522 (Indirect) | View |
| 2009-05-28 Sale |
2009-05-29 6:57 pm |
MAP Pharmaceuticals, Inc. | MAPP | FirstMark Capital, L.L.C. (See Footnote 1) | 46,787 | $13.34 | $624,036 | 2,342,972 (Indirect) |
View |
| 2009-05-28 Sale |
2009-05-29 5:45 pm |
MAP Pharmaceuticals, Inc. | MAPP | FirstMark Capital, L.L.C. (See Footnote 1) | 63,148 | $13.19 | $833,220 | 2,389,759 (Indirect) |
View |
| 2009-05-28 Sale | 2009-05-29 4:40 pm |
MAP Pharmaceuticals, Inc. | MAPP | FirstMark Capital, L.L.C. (See Footnote 1) | 46,452 | $13.12 | $609,352 | 2,452,907 (Indirect) | View |
| 2009-05-27- -2009-05-28 Sale | 2009-05-29 3:37 pm |
MAP Pharmaceuticals, Inc. | MAPP | FirstMark Capital, L.L.C. (See Footnote 1) | 87,163 | $12.96 | $1,129,640 | 2,499,359 (Indirect) |
View |
| 2009-05-26- -2009-05-27 Sale |
2009-05-28 4:21 pm | MAP Pharmaceuticals, Inc. | MAPP | ARMER THOMAS A (Chief Scientific Officer Director) | 100,000 | $9.606 | $960,600 | 332,403 (Indirect) | View |
| 2009-03-05 Purchase | 2009-03-09 10:03 am | MAP Pharmaceuticals, Inc. | MAPP | NELSON TIMOTHY S (President and CEO, Director Director) | 10,000 | $2.166 | $21,660 | 15,294 (Direct) |
View |
| 2007-10-05 Purchase | 2007-10-15 2:07 pm |
MAP Pharmaceuticals, Inc. | MAPP | FERRANTE DOMENIC J BROOKSIDE CAPITAL MANAGEMENT LLC BROOKSIDE CAPITAL INVESTORS L P BROOKSIDE CAPITAL PARTNERS FUND LP (10% owner) | 600,000 | $12 | $7,200,000 | 600,000 (Indirect) |
View |
| 2007-10-11 Purchase | 2007-10-12 4:35 pm |
MAP Pharmaceuticals, Inc. | MAPP | PERSEUS BIOTECH FUND PARTNERS LLC PERSEUSPUR LLC PEARL FRANK H (10% owner) | 175,000 | $12 | $2,100,000 | 4,076,170 (Direct) | View |
| 2007-10-11 Purchase | 2007-10-12 4:33 pm |
MAP Pharmaceuticals, Inc. | MAPP | PERSEUS SOROS BIOPHARMACEUTICAL FUND LP PERSEUS SOROS PARTNERS LLC SFM PARTICIPATION LP SFM AH LLC SOROS FUND MANAGEMENT LLC SOROS GEORGE Soros Robert SOROS JONATHAN T ALLAN (10% owner) | 175,000 | $12 | $2,100,000 | 4,076,170 (Direct) | View |
(C) Indicate conflicting filing codes (D in column 4 while P/A in column 3), interpreted as SALE.
Other transactions:
| Transaction & Date | Reported Date | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Ownership | Filing |
| 2009-11-18 Exercise |
2009-11-19 4:31 pm | MAP Pharmaceuticals, Inc. | MAPP | HENWOOD GERALDINE (Director) | 16,250 | $0.6411 | $10,418 | 16,250 (Direct) |
View |
| 2009-11-02 Exercise | 2009-11-04 2:15 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 4,500 | $0.7434 | $3,345 | 5,229 (Direct) |
View |
| 2009-11-02 Exercise |
2009-11-04 2:13 pm |
MAP Pharmaceuticals, Inc. | MAPP | CHAI CHRISTOPHER Y (Chief Financial Officer) | 10,000 | $0.7434 | $7,434 | 14,979 (Direct) |
View |
| 2009-10-01 Exercise |
2009-10-05 5:19 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 4,500 | $0.7434 | $3,345 | 5,229 (Direct) | View |
| 2009-10-01 Exercise | 2009-10-05 5:15 pm | MAP Pharmaceuticals, Inc. | MAPP | CHAI CHRISTOPHER Y (Chief Financial Officer) | 10,000 | $0.7434 | $7,434 | 14,979 (Direct) | View |
| 2009-09-08 Exercise | 2009-09-10 12:02 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 4,500 | $0.7434 | $3,345 | 5,229 (Direct) |
View |
| 2009-07-10 Exercise |
2009-07-14 5:26 pm | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 25,000 | $0.7434 | $18,585 | 25,729 (Direct) |
View |
| 2009-05-27 Exercise | 2009-05-28 4:21 pm |
MAP Pharmaceuticals, Inc. | MAPP | ARMER THOMAS A (Chief Scientific Officer Director) | 60,000 | $0.7434 | $44,604 | 392,403 (Indirect) |
View |
| 2007-10-11 Other Purchase | 2007-10-15 2:07 pm |
MAP Pharmaceuticals, Inc. | MAPP | FERRANTE DOMENIC J BROOKSIDE CAPITAL MANAGEMENT LLC BROOKSIDE CAPITAL INVESTORS L P BROOKSIDE CAPITAL PARTNERS FUND LP (10% owner) | 2,399,526 | $0.69 | $1,655,577 | 2,999,526 (Indirect) |
View |
| 2007-10-11 Purchase | 2007-10-12 4:35 pm | MAP Pharmaceuticals, Inc. | MAPP | PERSEUS BIOTECH FUND PARTNERS LLC PERSEUSPUR LLC PEARL FRANK H (10% owner) | 3,626,764 | $0 | $0 | 3,901,170 (Direct) | View |
| 2007-10-11 Purchase |
2007-10-12 4:33 pm |
MAP Pharmaceuticals, Inc. | MAPP | PERSEUS SOROS BIOPHARMACEUTICAL FUND LP PERSEUS SOROS PARTNERS LLC SFM PARTICIPATION LP SFM AH LLC SOROS FUND MANAGEMENT LLC SOROS GEORGE Soros Robert SOROS JONATHAN T ALLAN (10% owner) | 3,626,764 | $0 | $0 | 3,901,170 (Direct) |
View |
| 2007-10-11 Other Purchase |
2007-10-12 3:02 pm |
MAP Pharmaceuticals, Inc. | MAPP | Skyline Venture Partners Qualified Purchaser Fund III, L.P. (10% owner) | 1,767,659 | $14.5 | $25,634,591 | 1,850,992 (Indirect) |
View |
| 2007-10-11 Other Purchase |
2007-10-12 3:01 pm |
MAP Pharmaceuticals, Inc. | MAPP | Bay City Capital Fund IV, L.P. (10% owner) | 2,347,077 | $14.5 | $34,037,311 | 2,347,077 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction & Date |
Reported Date | Exercisable Expiration | Company | Symbol | Insider Relationship |
Shares Traded |
Conversion Price | Shares Ownership |
Filing |
| 2009-11-18 Exercise |
2009-11-19 4:31 pm | N/A 2015-05-09 |
MAP Pharmaceuticals, Inc. | MAPP | HENWOOD GERALDINE (Director) | 16,250 | $0.6411 | 1,627 (Direct) |
View |
| 2009-11-02 Exercise |
2009-11-04 2:15 pm |
N/A 2016-10-16 |
MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 4,500 | $0.7434 | 53,143 (Direct) |
View |
| 2009-11-02 Exercise |
2009-11-04 2:13 pm | N/A 2016-10-16 | MAP Pharmaceuticals, Inc. | MAPP | CHAI CHRISTOPHER Y (Chief Financial Officer) | 10,000 | $0.7434 | 119,122 (Direct) | View |
| 2009-10-01 Exercise |
2009-10-05 5:19 pm |
N/A 2016-10-16 | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 4,500 | $0.7434 | 57,643 (Direct) |
View |
| 2009-10-01 Exercise |
2009-10-05 5:15 pm |
N/A 2016-10-16 | MAP Pharmaceuticals, Inc. | MAPP | CHAI CHRISTOPHER Y (Chief Financial Officer) | 10,000 | $0.7434 | 129,122 (Direct) | View |
| 2009-09-08 Exercise | 2009-09-10 12:02 pm |
N/A 2016-10-16 | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 4,500 | $0.7434 | 62,143 (Direct) | View |
| 2009-07-10 Exercise | 2009-07-14 5:26 pm | N/A 2016-10-16 | MAP Pharmaceuticals, Inc. | MAPP | GIANAKAKOS ANASTASIOS (SVP, Cor & Business Dev) | 25,000 | $0.7434 | 66,643 (Direct) |
View |
| 2009-05-27 Exercise |
2009-05-28 4:21 pm | N/A 2016-01-23 |
MAP Pharmaceuticals, Inc. | MAPP | ARMER THOMAS A (Chief Scientific Officer Director) | 60,000 | $0.7434 | 35,846 (Direct) | View |
| 2009-05-21 Other | 2009-05-26 4:18 pm | N/A 2019-05-20 | MAP Pharmaceuticals, Inc. | MAPP | SOROS FUND MANAGEMENT LLC SOROS GEORGE Soros Robert SOROS JONATHAN T ALLAN (10% owner) | 7,500 | $3.18 | 7,500 (Indirect) |
View |
| 2009-05-21 Other | 2009-05-26 4:16 pm | N/A 2019-05-20 | MAP Pharmaceuticals, Inc. | MAPP | PEARL FRANK H (10% owner) | 7,500 | $3.18 | 7,500 (Indirect) | View |
| 2009-05-21 Option Award |
2009-05-22 5:54 pm |
N/A 2019-05-20 |
MAP Pharmaceuticals, Inc. | MAPP | Freund John Gordon (Director) | 7,500 | $3.18 | 7,500 (Direct) | View |
| 2009-05-21 Option Award |
2009-05-22 5:53 pm |
N/A 2019-05-20 |
MAP Pharmaceuticals, Inc. | MAPP | GOLDFISCHER CARL (Director) | 7,500 | $3.18 | 7,500 (Direct) |
View |
| 2009-05-21 Option Award |
2009-05-22 5:52 pm | N/A 2019-05-20 | MAP Pharmaceuticals, Inc. | MAPP | Wolff Henry Ward (Director) | 7,500 | $3.18 | 7,500 (Direct) |
View |
| 2009-05-21 Option Award | 2009-05-22 5:49 pm | N/A 2019-05-20 |
MAP Pharmaceuticals, Inc. | MAPP | KELLEY BERNARD J (Director) | 7,500 | $3.18 | 7,500 (Direct) | View |
| 2009-05-21 Option Award |
2009-05-22 5:41 pm |
N/A 2019-05-20 | MAP Pharmaceuticals, Inc. | MAPP | WARD SCOTT R (Director) | 7,500 | $3.18 | 7,500 (Direct) |
View |
| 2009-05-21 Option Award |
2009-05-22 5:05 pm | N/A 2019-05-20 |
MAP Pharmaceuticals, Inc. | MAPP | MCPHERRON MATTHEW V (Director 10% owner) | 7,500 | $3.18 | 7,500 (Direct) | View |
| 2009-02-11 Option Award | 2009-02-13 5:08 pm | N/A 2019-02-10 |
MAP Pharmaceuticals, Inc. | MAPP | Friedman Charlene A (VP President, Gen Counsel &Sec) | 75,000 | $10.37 | 75,000 (Direct) |
View |
| 2009-02-11 Option Award | 2009-02-13 5:07 pm | N/A 2019-02-10 | MAP Pharmaceuticals, Inc. | MAPP | KELLERMAN DONALD J (SVP,Clinical Dev & Med Affairs) | 35,000 | $10.37 | 35,000 (Direct) |
View |
| 2008-05-22 Option Award |
2008-05-22 6:47 pm | N/A 2018-05-21 | MAP Pharmaceuticals, Inc. | MAPP | ELMS STEVE (Director) | 7,500 | $12.19 | 7,500 (Direct) | View |
| 2008-01-22 Option Award |
2008-01-24 6:53 pm |
N/A 2018-01-21 | MAP Pharmaceuticals, Inc. | MAPP | SHREWSBURY STEPHEN B (Chief Medical Officer) | 40,000 | $13.12 | 40,000 (Direct) |
View |
| 2007-10-11 Purchase |
2007-10-15 2:07 pm |
N/A N/A | MAP Pharmaceuticals, Inc. | MAPP | FERRANTE DOMENIC J BROOKSIDE CAPITAL MANAGEMENT LLC BROOKSIDE CAPITAL INVESTORS L P BROOKSIDE CAPITAL PARTNERS FUND LP (10% owner) | 1,120,975 | $0 | 0 (Indirect) |
View |
| 2007-10-11 Purchase | 2007-10-15 2:07 pm | N/A N/A |
MAP Pharmaceuticals, Inc. | MAPP | FERRANTE DOMENIC J BROOKSIDE CAPITAL MANAGEMENT LLC BROOKSIDE CAPITAL INVESTORS L P BROOKSIDE CAPITAL PARTNERS FUND LP (10% owner) | 1,164,389 | $0 | 0 (Indirect) | View |
| 2007-10-11 Purchase |
2007-10-12 4:35 pm |
N/A N/A |
MAP Pharmaceuticals, Inc. | MAPP | PERSEUS BIOTECH FUND PARTNERS LLC PERSEUSPUR LLC PEARL FRANK H (10% owner) | 610,168 | $0 | 0 (Direct) |
View |
| 2007-10-11 Purchase |
2007-10-12 4:35 pm |
N/A N/A |
MAP Pharmaceuticals, Inc. | MAPP | PERSEUS BIOTECH FUND PARTNERS LLC PERSEUSPUR LLC PEARL FRANK H (10% owner) | 1,403,766 | $0 | 0 (Direct) | View |
| 2007-10-11 Purchase | 2007-10-12 4:35 pm |
N/A N/A |
MAP Pharmaceuticals, Inc. | MAPP | PERSEUS BIOTECH FUND PARTNERS LLC PERSEUSPUR LLC PEARL FRANK H (10% owner) | 828,147 | $0 | 0 (Direct) |
View |
| 2007-10-11 Purchase |
2007-10-12 4:35 pm | N/A N/A |
MAP Pharmaceuticals, Inc. | MAPP | PERSEUS BIOTECH FUND PARTNERS LLC PERSEUSPUR LLC PEARL FRANK H (10% owner) | 784,683 | $0 | 0 (Direct) |
View |
| 2007-10-11 Purchase | 2007-10-12 4:33 pm |
N/A N/A | MAP Pharmaceuticals, Inc. | MAPP | PERSEUS SOROS BIOPHARMACEUTICAL FUND LP PERSEUS SOROS PARTNERS LLC SFM PARTICIPATION LP SFM AH LLC SOROS FUND MANAGEMENT LLC SOROS GEORGE Soros Robert SOROS JONATHAN T ALLAN (10% owner) | 610,168 | $0 | 0 (Direct) | View |
| 2007-10-11 Purchase |
2007-10-12 4:33 pm |
N/A N/A | MAP Pharmaceuticals, Inc. | MAPP | PERSEUS SOROS BIOPHARMACEUTICAL FUND LP PERSEUS SOROS PARTNERS LLC SFM PARTICIPATION LP SFM AH LLC SOROS FUND MANAGEMENT LLC SOROS GEORGE Soros Robert SOROS JONATHAN T ALLAN (10% owner) | 1,403,766 | $0 | 0 (Direct) | View |
| 2007-10-11 Purchase | 2007-10-12 4:33 pm |
N/A N/A | MAP Pharmaceuticals, Inc. | MAPP | PERSEUS SOROS BIOPHARMACEUTICAL FUND LP PERSEUS SOROS PARTNERS LLC SFM PARTICIPATION LP SFM AH LLC SOROS FUND MANAGEMENT LLC SOROS GEORGE Soros Robert SOROS JONATHAN T ALLAN (10% owner) | 828,147 | $0 | 0 (Direct) |
View |
| 2007-10-11 Purchase | 2007-10-12 4:33 pm |
N/A N/A |
MAP Pharmaceuticals, Inc. | MAPP | PERSEUS SOROS BIOPHARMACEUTICAL FUND LP PERSEUS SOROS PARTNERS LLC SFM PARTICIPATION LP SFM AH LLC SOROS FUND MANAGEMENT LLC SOROS GEORGE Soros Robert SOROS JONATHAN T ALLAN (10% owner) | 784,683 | $0 | 0 (Direct) | View |
| 2007-10-11 Purchase | 2007-10-12 3:02 pm |
N/A N/A |
MAP Pharmaceuticals, Inc. | MAPP | Skyline Venture Partners Qualified Purchaser Fund III, L.P. (10% owner) | 779,871 | $0 | 0 (Direct) | View |
| 2007-10-11 Purchase | 2007-10-12 3:02 pm | N/A N/A | MAP Pharmaceuticals, Inc. | MAPP | Skyline Venture Partners Qualified Purchaser Fund III, L.P. (10% owner) | 320,690 | $0 | 0 (Direct) |
View |
| 2007-10-11 Purchase |
2007-10-12 3:02 pm |
N/A N/A |
MAP Pharmaceuticals, Inc. | MAPP | Skyline Venture Partners Qualified Purchaser Fund III, L.P. (10% owner) | 538,236 | $0 | 0 (Direct) |
View |
| 2007-10-11 Purchase | 2007-10-12 3:01 pm |
N/A N/A |
MAP Pharmaceuticals, Inc. | MAPP | Bay City Capital Fund IV, L.P. (10% owner) | 1,091,815 | $0 | 0 (Direct) |
View |
| 2007-10-11 Purchase |
2007-10-12 3:01 pm |
N/A N/A |
MAP Pharmaceuticals, Inc. | MAPP | Bay City Capital Fund IV, L.P. (10% owner) | 448,963 | $0 | 0 (Direct) |
View |
| 2007-10-11 Purchase | 2007-10-12 3:01 pm | N/A N/A |
MAP Pharmaceuticals, Inc. | MAPP | Bay City Capital Fund IV, L.P. (10% owner) | 629,829 | $0 | 0 (Direct) |
View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Fri, 20 Nov 2009 20:24:47 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |